Search
Methapyrilene
go.drugbank.com/drugs/DB04819ApprovedWithdrawnMethapyrilene, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.
Synonyms: N-(α-pyridyl)-N-(α-thenyl)-N',N'-dimethylethylenediamine, N,N-dimethyl-N'-pyrid-2-yl-N'-2-thenylethylenediamineRGN6024
go.drugbank.com/drugs/DB33059Experimentalcells, and suppresses tumor growth in glioblastoma xenograft models. … Reglagene announced FDA orphan drug designation for glioblastoma in 2024. RGN6024 remains investigational and is not an approved drug.
MW33
go.drugbank.com/drugs/DB16358Experimental[L27411] This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection). … MW33 is a recombinant fully human antibody to SARS-CoV-2.
Fenticonazole
go.drugbank.com/drugs/DB13434InvestigationalFenticonazole has a broad spectrum of antimycotic activity against dermatophytes and yeasts.
Tenamfetamine
go.drugbank.com/drugs/DB01509IllicitInvestigationalIt is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [PubChem] … An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen.
Isopentane
go.drugbank.com/drugs/DB16203InvestigationalIsopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization/fluoride Uptake in an in Situ Model).
Rexlemestrocel-L
go.drugbank.com/drugs/DB17606InvestigationalIt is being investigated in various cardiac conditions, such as chronic heart failure and acute myocardial infarction. … Rexlemestrocel-L is an investigational human bone marrow-derived allogeneic mesenchymal precursor cell (MPC) product.
Ertumaxomab
go.drugbank.com/drugs/DB18923InvestigationalErtumaxomab is under investigation in clinical trial NCT00522457 (Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy).